Become a Partner

admin

|

|

Daily Voice: Despite steep tariffs, OmniScience’s Vikas Gupta sees strong earnings recovery in 2HFY26

Moneycontrol: Daily Voice: Time to book profits in pharma, Zomato looks overvalued, says portfolio manager

 Despite the hefty tariff rate of 50 percent, Vikas Gupta, the CEO and Chief Investment Strategist at OmniScience Capital, still anticipates a strong earnings recovery in the second half of FY26. “The tariffs shouldn’t have too much impact on the earnings of most sectors,” he said in an interview to Moneycontrol.

Read More

Recent Posts

Archive

Previous Post
Next Post
Accessibility by WAH